151 related articles for article (PubMed ID: 1741644)
1. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene.
Motojima K; Tsunoda T; Kanematsu T; Nagata Y; Urano T; Shiku H
Ann Surg; 1991 Dec; 214(6):657-62. PubMed ID: 1741644
[TBL] [Abstract][Full Text] [Related]
2. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
3. Analysis of K-ras gene mutations in periampullary cancers, gallbladder cancers and cholangiocarcinomas from paraffin-embedded tissue sections.
Lee JC; Lin PW; Lin YJ; Lai J; Yang HB; Lai MD
J Formos Med Assoc; 1995 Dec; 94(12):719-23. PubMed ID: 8541732
[TBL] [Abstract][Full Text] [Related]
4. Analysis of K-ras gene mutations in rare pancreatic and ampullary tumours.
Ebert MP; Hoffmann J; Schneider-Stock R; Kasper HU; Schulz HU; Lippert H; Roessner A; Malfertheiner P
Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1025-9. PubMed ID: 9895049
[TBL] [Abstract][Full Text] [Related]
5. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.
Malats N; Porta M; Piñol JL; Corominas JM; Rifà J; Real FX
J Clin Oncol; 1995 Jul; 13(7):1679-86. PubMed ID: 7602358
[TBL] [Abstract][Full Text] [Related]
6. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
7. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma.
Motojima K; Urano T; Nagata Y; Shiku H; Tsurifune T; Kanematsu T
Ann Surg; 1993 Feb; 217(2):138-43. PubMed ID: 8439212
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.
Motojima K; Urano T; Nagata Y; Shiku H; Tsunoda T; Kanematsu T
Am J Gastroenterol; 1991 Dec; 86(12):1784-8. PubMed ID: 1962623
[TBL] [Abstract][Full Text] [Related]
9. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.
Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S
Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992
[TBL] [Abstract][Full Text] [Related]
10. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
[TBL] [Abstract][Full Text] [Related]
11. Frequent somatic mutations of the APC and p53 genes in sporadic ampullary carcinomas.
Imai Y; Oda H; Tsurutani N; Nakatsuru Y; Inoue T; Ishikawa T
Jpn J Cancer Res; 1997 Sep; 88(9):846-54. PubMed ID: 9369932
[TBL] [Abstract][Full Text] [Related]
12. ras-family gene mutations in neoplasia of the ampulla of Vater.
Scarpa A; Zamboni G; Achille A; Capelli P; Bogina G; Iacono C; Serio G; Accolla RS
Int J Cancer; 1994 Oct; 59(1):39-42. PubMed ID: 7927901
[TBL] [Abstract][Full Text] [Related]
13. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing.
Tada M; Yokosuka O; Omata M; Ohto M; Isono K
Cancer; 1990 Sep; 66(5):930-5. PubMed ID: 2167148
[TBL] [Abstract][Full Text] [Related]
15. K-ras mutation in adenomas and carcinomas of the ampulla of vater.
Howe JR; Klimstra DS; Cordon-Cardo C; Paty PB; Park PY; Brennan MF
Clin Cancer Res; 1997 Jan; 3(1):129-33. PubMed ID: 9815548
[TBL] [Abstract][Full Text] [Related]
16. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
[TBL] [Abstract][Full Text] [Related]
17. K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.
Wenger FA; Zieren J; Peter FJ; Jacobi CA; Müller JM
Langenbecks Arch Surg; 1999 Apr; 384(2):181-6. PubMed ID: 10328172
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of K-ras oncogene activation in ampullary neoplasms.
Chung CH; Wilentz RE; Polak MM; Ramsoekh TB; Noorduyn LA; Gouma DJ; Huibregtse K; Offerhaus GJ; Slebos RJ
J Clin Pathol; 1996 Jun; 49(6):460-4. PubMed ID: 8763258
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis of periampullary carcinomas at MR imaging.
Kim JH; Kim MJ; Chung JJ; Lee WJ; Yoo HS; Lee JT
Radiographics; 2002; 22(6):1335-52. PubMed ID: 12432106
[TBL] [Abstract][Full Text] [Related]
20. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
